Is EINECS 238-483-7 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use EINECS 238-483-7? Is EINECS 238-483-7 safe for nursing mother and child? Does EINECS 238-483-7 extracts into breast milk? Does EINECS 238-483-7 has any long term or short term side effects on infants? Can EINECS 238-483-7 influence milk supply or can EINECS 238-483-7 decrease milk supply in lactating mothers?
EINECS 238-483-7 lactation summary
- DrLact safety Score for EINECS 238-483-7 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of EINECS 238-483-7 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that EINECS 238-483-7 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of EINECS 238-483-7 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using EINECS 238-483-7 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About EINECS 238-483-7 usage in lactation
Drug which is oxazolinic-derived from Prednisolone with similar properties to the latter. At latest update no published data on excretion into breast milk were found. Due to a moderate high molecular weight and rapid elimination time it is probably safe while breastfeeding, mostly in non long-term treatments. Until more data on this drug is available, it would be preferred other options that are known to be safer, specially during the neonatal period and prematurity.
Answer by DrLact: About EINECS 238-483-7 usage in lactation
Because no information is available on the use of EINECS 238-483-7 during breastfeeding, an alternate corticosteroid may be preferred, especially while nursing a newborn or preterm infant.
EINECS 238-483-7 Side Effects in Breastfeeding
None reported with any corticosteroid.
Alternate Drugs
Clobetasol(Safe)
Flunisolide(Safe)
Hydrocortisone(Safe)
Prednisone(Safe)
Dexamethasone(Low Risk)
Betamethasone(Low Risk)
Fluticasone, Inhaled(Safe)
Prednisolone(Safe)
Dexamethasone, Topical(Low Risk)
Betamethasone, Topical(Low Risk)
Natalizumab(Low Risk)
Fluticasone, Topical(Safe)
Ciclesonide(Safe)
Deflazacort(Low Risk)
Hydrocortisone, Topical(Safe)
Methylprednisolone(Safe)
Methylprednisolone(Safe)
Hydrocortisone(Safe)
Prednisone(Safe)
Dexamethasone(Low Risk)
Betamethasone(Low Risk)
Prednisolone(Safe)
Deflazacort(Low Risk)
Clobetasol(Safe)
Flunisolide(Safe)
Hydrocortisone(Safe)
Prednisone(Safe)
Dexamethasone(Low Risk)
Betamethasone(Low Risk)
Fluticasone, Inhaled(Safe)
Prednisolone(Safe)
Dexamethasone, Topical(Low Risk)
Fluticasone, Topical(Safe)
Betamethasone, Topical(Low Risk)
Ciclesonide(Safe)
Deflazacort(Low Risk)
Hydrocortisone, Topical(Safe)
Methylprednisolone(Safe)